Bionano Genomics, Inc. (BNGO) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Bionano Genomics, Inc. (BNGO) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $4.1M, listed on NASDAQ, employing roughly 98 people, carrying a beta of 1.65 to the broader market. Bionano Genomics, Inc. Led by Robert Erik Holmlin, public since 2018-08-21.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for BNGO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →